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Abstract: Retinal pigment epithelium (RPE) acts as an outer blood–retinal barrier that limits the
access of circulating xenobiotics to the eye. In addition, the RPE limits posterior elimination of
intravitreally injected drugs to circulation. Thus, permeation in the RPE has a significant effect
on ocular pharmacokinetics. The RPE is also a potentially important drug target in age-related
macular degeneration. Therefore, the cell models of the RPE are important tools in ocular drug
development, but poor availability and problems in reproducibility limit the use of primary RPE cell
cultures. Furthermore, the best and widely used human cell line ARPE19 requires specialized culture
conditions and a long time for cellular differentiation. In this paper, we describe a cell population
arisen from the ARPE19 culture, with fast differentiation and improved barrier properties. This
cell line, LEPI, forms clear microvilli and rapidly displays RPE-like cobblestone morphology after
subculture in simple culture conditions. The LEPI cells show RPE-specific functions and expression
of RPE65, ezrin, and BEST1 proteins. On filter, the LEPI cells develop tighter barrier than the ex vivo
bovine RPE-choroid: permeability coefficients of beta-blockers (atenolol, nadolol, timolol, pindolol,
metoprolol, betaxolol) ranged from 0.4 × 10−6 cm/sec to 2.3 × 10−6 cm/sec depending on the drug
lipophilicity. This rapidly differentiating cell line will be an asset in ocular studies since it is easily
maintained, it grows and differentiates quickly and does not require specialized culture conditions
for differentiation. Thus, this cell line is suitable for both small scale assays and high throughput
screening in drug discovery and development.
Keywords: retinal pigment epithelium; outer blood–retinal barrier; cell line; ARPE19; differentiation;
tight junctions; microvilli; drug permeation; beta-blockers
1. Introduction
Retinal pigment epithelium (RPE) separates the choroidal blood flow from the neural retina,
thereby forming the outer part of the blood–retinal barrier. The RPE has an important role in ocular
pharmacokinetics since the inter-cellular tight junctions restrict the distribution of drugs and other
xenobiotics from the choroidal bloodstream into the inner parts of the eye [1,2]. The RPE also supports
visual functions; for instance, it maintains optimal ion balance in the sub-retinal space that supports
the well-being of the photoreceptors of the neural retina. The RPE secretes growth factors, participates
in retinoid cycling, phagocytoses shed photoreceptor outer segments (POS) and provides nutrients for
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the neural retina [1]. Disturbances in RPE functions are involved in many sight-threatening diseases,
such as diabetic retinopathy and age-related macular degeneration (AMD) [3] making the RPE subject
to intensive medical and pharmaceutical research.
The ARPE19 cell line is widely used as a cell model of the RPE. This cell line spontaneously
differentiated from a primary human RPE cell culture [4]. The original ARPE19 study showed
cobblestone morphology, formation of tight junctions and microvilli, and expression of RPE-specific
genes (RPE65, CRALBP) in the cell cultures [4]. Furthermore, the differentiated ARPE19 cells
on filter showed polarized secretion of vascular endothelial growth factor (VEGF) and pigment
epithelium-derived factor (PEDF) [5]. Permeation of test compounds across differentiated ARPE19
cells on filter was dependent on the molecular size and lipophilicity of the solutes, but the ARPE19
cultures were more permeable than isolated bovine RPE-choroid specimens [6,7]. The ARPE19 cell
model also displays a similar, but not identical, transporter expression profile with human primary RPE
cells (hfRPE cells) [8]. Compared to another human RPE cell line (D407), ARPE19 is considered to be a
better model, since ARPE19 can form tight junctions that were not detected in D407 cultures [9]. Since
the use of primary RPE cultures is limited by restricted availability of the cells, limited passaging and
problems of reproducibility, ARPE19 cell line has become a widely used alternative model. However,
differentiation of ARPE19 cells takes a long time (1–4 months) both on filters [5,6,10] and in the
regular culture dishes [8,10,11]. Furthermore, the reported properties of the ARPE19 cell line vary
between different laboratories as the original phenotype of the cell line has undergone a degradation
among passaging [9]. Therefore, different routines (culture surfaces, medium composition, seeding
densities, culture times) are used to restore the proper phenotype. Some studies have reported a loss
of RPE specific phenotype due to the downregulation or lack of RPE-specific gene expression (e.g.,
RPE65) [10,12], and the gene expression of ARPE19 cells varies in different culture conditions [13].
Recently, we observed a distinct cobblestone cell population in our ARPE19 cultures that were
maintained in regular culture medium on un-coated culture dishes. Due to the fast proliferation of
these cuboidal RPE-like cells, they gradually overcame the ARPE19 cells in the cultures. Herein, we
describe the characterization of this new ARPE19 derived cell line that was named LEPI. This cell
model has significant advantages making it an attractive research tool in RPE research.
2. Materials and Methods
2.1. Cell Culture
After recognition of the morphologically different cell population among the ARPE19 cultures (at
passage 27, product CRL-2302, American Type Culture Collection, ATCC, Manassas, VA, USA), the
cells were sub-cultured at several seeding densities (1:10, 1:15, and 1:30) with trypsin-EDTA (0.05%,
Gibco, Thermo Fisher Scientific, Waltham, MA, USA). After this passage (p-28), the cell population
consisted only of the cells with cobblestone morphology on all cell plates. The culture routine was
changed to lower sub-culture densities as the cells expanded into confluency in 2 to 4 days after seeding.
After passage 28, the cells were identified as LEPI cells, and their passage number was switched to 1.
All the studies described in this paper have been conducted with LEPI cells of passages 2 to 17. We
have not done experiments with cells beyond passage 17, but we do not anticipate major differences in
later passages in LEPI cells maintaining their cobblestone morphology.
The routine culture of the LEPI cells involves weekly sub-culture with 1:30 to 1:50 seeding densities
and maintenance in DMEM-F12 medium (Gibco, Thermo Fisher Scientific) with 10% fetal bovine serum
(FBS; Gibco, Thermo Fisher Scientific), 1% penicillin-streptomycin and 2 mM l-glutamine (both from
Euroclone, Pero, Italy). The same medium composition was used with the regular ARPE19 cell culture
in our laboratory.
Human primary RPE cells (hfRPE cells, HRPEpiC, ScienCell, Carlsbad, CA, USA) were expanded
and cultured, as described previously [8].
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Identity of all three RPE models (ARPE19, LEPI, hfRPE) was examined using short-tandem repeat
profiling (STR). STR analysis and profiling against the ATCC’s cell STR database was conducted as
Cell Line Authentication service in ATCC as described previously [14].
2.2. Transmission and Scanning Electron Microscopy
For transmission electron microscopy (TEM: JEM2100F, JEOL Ltd., Tokyo, Japan), ARPE19
(105,000 cells/cm2), LEPI (105,000 cells/cm2) and HRPEpiC (hfRPE cells, 210,000 cells/cm2) cells were
seeded on 24 well plates. For scanning electron microscopy (SEM; Sigma HD|VP, Carl Zeiss Microscopy
GmbH, Jena, Germany), the cells were seeded on glass coverslips in 24 well plates at the same cell
density as in TEM studies. After two weeks in culture, the cells were fixed, processed, and imaged at
SibLabs Kuopio (Science Innovation Business Lab, Kuopio, Finland).
2.3. Immunofluorescence Staining
The LEPI cells were seeded onto ibidi µ-slides (80826, Ibidi GmbH, Gräfelfing, Germany) and
cultured for 18 days before the immunofluorescence staining for the RPE-specific proteins and 7 days
before characterization of the fluid-filled domes. The cells were fixed with 100% methanol (at −20 ◦C)
and stained with primary antibodies for immunofluorescence (Table 1) together with specific Alexa
Fluor secondary antibodies (Thermo Fisher Scientific). Cell nuclei were stained with 1:10,000 dilution
of DAPI (D9542 Sigma Aldrich, Saint Louis, MO, USA) and visualized with Zeiss LSM 800 Airyscan
confocal microscope (Carl Zeiss LSM 800, Carl Zeiss Microscopy GmbH, Jena, Germany).
Table 1. The antibody information.
Primary
Antibody Cat n:o and Vendor Dilution
Secondary
Antibody
Cat n:o and
Vendor Dilution
ezrin sc-58758, Santa CruzBiotechnology 1:100
goat anti-mouse
AF594
A-11032 Thermo
Fischer Scientific 1:1000
occludin 71-1500, ThermoFischer Scientific 1:100
goat anti-rabbit
AF488
A-11034 Thermo
Fischer Scientific 1:1000
RPE65 NB100-355, NovusBiologicals 1:100
goat anti-mouse
AF594
A-11032 Thermo
Fischer Scientific 1:1000
MRP1 ab3368, Abcam 1:100 goat anti-RatAF568
A-11029 Thermo
Fischer Scientific 1:1000
2.4. Phagocytosis Assay
Isolation of photoreceptor outer segments (POS) from porcine eyes and labeling with fluorescein
isothiocyanate (FITC) was carried out as described earlier [8] (Supplement: Characterization of human
fetal retinal pigment epithelial (hfRPE) cells).
For phagocytosis assay, the cells were seeded on Ibidiµ-slides (80826) at cell density 45,000 cells/cm2.
After culturing for one week, the cells were incubated with 10 µg of labeled FITC-POS/cm2 for 20 h.
After incubation, the cells were washed four times with PBS to remove all FITC-POS that had not been
phagocytosed. Eventually, the cells were fixed and counterstained with MRP1 antibody as described
above (Immunofluorescence staining).
2.5. Doubling Time
The proliferation of ARPE19 and LEPI cells was characterized by cell doubling-time assays. For
the assay, the cells were seeded onto 6-well plates at low density (0.15 million cells/well). After 48 h
and at the sub-confluent stage, the cells were detached by trypsinization and counted with Bürker
hemocytometer. The doubling times of the cell lines were calculated using Equation (1).
DT = Tln2/ln(Xe/Xb), (1)
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where T is the incubation time, ln stands for the natural logarithm, Xb is the cell number at the start,
and Xe is the cell number at the end of the culturing.
2.6. Permeability Studies
For the permeability experiments, the cells were seeded at 160,000 cells/cm2 onto 1.12 cm2 polyester
filters with 0.4 µM pore size (3460-Clear Transwells, Corning Inc., Corning, NY, USA). The cells were
cultured for 1 to 4 weeks in DMEM-F12 containing 1% FBS, 1% penicillin-streptomycin, and 2 mM
l-glutamine, and the growth medium was replaced 3 times a week. The same procedure was used for
both regular ARPE19 and LEPI cells.
The permeation was studied in apical-to-basolateral direction. Mannitol (3H-labeled mannitol,
Perkin Elmer, Waltham, MA, USA) was used as a paracellular marker. Permeability of atenolol,
metoprolol, nadolol, pindolol, timolol (all from Sigma Aldrich) and betaxolol (Alcon, Fort Worth,
TX, USA) was investigated. The permeability assay with mannitol was conducted with LEPI and
ARPE19 cultures (original ATCC’s product CRL-2302). The beta-blocking drugs (atenolol, metoprolol,
nadolol, pindolol, timolol, betaxolol) were administered as cassette solution, with 10 µM of each drug
in HBSS-Hepes (10 mM) buffer (pH 7.40). The experiments took place at 37 ◦C, and the cells were kept
on low-speed shaking (170 rpm Heidolph incubator 1000 and Titramax 1000, Heidolph Electro GmbH
& Co., Keiheim, Germany). The permeation was monitored by sampling the receiver phase at 15, 30,
45, 60, 75, 90, 120, 150, 180, 210, 240, 270, 300, 330, and 360 min.
The apparent permeability coefficients Papp (in cm/sec) were calculated with Equation (2) below.
Papp = J/(C0 × A), (2)
where J is the drug flux (ng/sec or cpm/sec) across the cell monolayer, C0 (ng/cm3 or cpm/cm3) is the
starting concentration, and A is the monolayer surface area (1.12 cm2). The sink conditions were
maintained during the linear phase of permeation. At that stage drug concentration in the receiver
compartment was maintained below 10% of the concentration in the donor compartment.
2.7. Drug Concentration Determination
The radioactivity counts of 3H-mannitol were determined with a liquid scintillation counter
(Microbeta Plus 1450, Perkin Elmer, Waltham, MA, USA) after equilibrating the samples overnight in
Ultima Gold® solution (Perkin Elmer).
The beta-blocker concentrations were analyzed with LC-MS/MS with previously described
methods [15,16] using a liquid chromatograph (Agilent 1290, Agilent Technologies, Inc., Santa Clara,
CA, USA) and a triple-quadrupole mass spectrometer (Agilent 6495; Agilent Technologies, Inc.,
Santa Clara, CA, USA) with electrospray ionization. The validation of the compound analysis has
been described in detail in our previous publications [15,16], and similar measures were undertaken to
validate the LC-MS/MS runs.
3. Results
3.1. Morphology of Rapidly Growing LEPI Cells Is Similar to Primary RPE Cultures
We observed round colonies with distinct cobblestone morphology in our regular ARPE19 cell
plates in passage 27 (Figure 1a,b). The morphology is different from regular ARPE19 cells, which are
clearly longer (Figure 1a–c), and the difference can be seen immediately after sub-culture (Figure 1c,d).
The LEPI cells retained their cuboidal morphology, even at low seeding densities (Figure 1d,e). The
authentication assay conducted by ATCC showed that the LEPI and ARPE19 cells are of the same
origin (Supplementary Materials) confirming that the LEPI cells are not a contamination from another
cell line.
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Figure 1. ARPE19 derived LEPI cells with cobblestone morphology arose from regular ARPE19 cultures.
The round cell colonies containing the LEPI cell population (marked with *) inside the ARPE19 cultures
showed distinct morphology compared to regular ARPE19 cells (a,b). At low culture densities, the
regular ARPE19 cells (c) display more spindle shape morphology compared to LEPI cells (d) that
instantly displayed cuboidal epithelial-like phenotype at 24 h after sub-culturing. The cells start to
display RPE-like morphology 3 days after sub-culturing at 1:30 density (e). Scale bars (a) 500 µM,
(b) 200 µM, (c–e) 100 µM.
Scanning electron microscopy revealed that LEPI cells (Figure 2e) and hfRPE cells (Figure 2c)
form clear microvilli, whereas microvilli were not detected in ARPE19 cells (Figure 2a). Transmission
electron micrographs demonstrate the presence of tight junctions in each cell model (Figure 2b,d,f).
LEPI (Figure 2f) and ARPE19 (Figure 2b) cells did not have pigmentation, whereas small vesicles,
which can be pre-melanosomes, were detected in hfRPE cells (Figure 2d).
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Figure 2. LEPI cells form similar tight junctions and microvilli with primary RPE cells. SEM imaging
was used to evaluate the microvilli formation (a,c,e). ARPE19 cells (a) do not form clear microvilli,
whereas hfRPE cells (c) and LEPI cells (e) display microvilli. Scale bars of SEM images (a,c,e) are 200 nm.
The TEM images show tight junctions (circled) in ARPE19 (b), hfRPE (d) and LEPI cells (f). ARPE19
TEM image scale bar is 2 µm (b), and the LEPI (f) and hfRPE (d) image scale bars are 500 nm.
3.2. LEPI Cells Display RPE-Specific Protein Expression and Function
We detected protein expression involved with tight junctions (occludin, Figure 3) and microvilli
(ezrin, Figure 3a) in LEPI cells. In addition, LEPI cells displayed RPE-specific protein expression
(RPE65, BEST1 Figure 3b,c) indicating proper cellular maturation. The cells also formed fluid-filled
domes that confirm proper apical-to-basolateral polarity and the presence of tight junctions (Figure 4).
Furthermore, the cells phagocytosed FITC-labeled photoreceptor outer segments that were isolated
from the porcine neural retina (Figure 3d).
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Figure 3. LEPI cells with mature RPE phenotype. Occludin was used in all (a–c) images to reveal the cell
shape and the presence of tight junctions (green). DAPI stain was used to visualize the cell nuclei (blue).
(a) Ezrin (red) was detected on the apical surface indicating proper microvilli formation. (b) LEPI cells
showed RPE-specific BEST1 expression on the basal membrane (red) and (c) RPE65 expression in the
cytoplasm (red). The cells were cultured 18 days before imaging. (d) Confocal microscope image of
LEPI cells cultured on Ibidi slides for one week. The cells were exposed to FITC labeled photoreceptor
outer segments (FITC-POS, green), and after 20 h incubation, the cells were washed and counterstained
with anti-MRP1 antibody (red) localized in lateral plasma membranes. The vertical section view (upper
panel) shows internalized FITC-POS in LEPI cells. Scale bars 10 µm.
Figure 4. As evidence for cellular polarity and presence of tight-junctions, increased number of
fluid-filled domes (*) were formed in LEPI cell cultures after 7 days of culturing. (a) Bright-field image
of LEPI cells on a culture dish. Scale bar 500 µm (b) Confocal microscope image of immunofluorescence
stained LEPI cells on ibidi slide, scale bar 20 µm. Lateral plasma membranes counterstained with
multi-drug resistance associated protein 1 (MRP1, red) and DAPI stained cell nuclei (blue). Inset
of boxed area displaying X-Z section view (apical/basal sides) of the fluid-filled dome (*) in the cell
monolayer. The domes are seen as holes in the images that display the top view of the culture. The
cells at that z-level are located above the section that is in focus (*).
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3.3. LEPI Cells Form an Appropriate Outer Blood–Retinal Barrier Model
We compared the doubling time among regular ARPE19 cells and the LEPI cells with RPE-like
morphology. Based on cell proliferation assay, the LEPI cells divided 2.3 times faster than regular
ARPE19 cells (Figure 5a), but the growth of LEPI cells is controlled by contact inhibition, and these
cells grow as a monolayer.
Figure 5. Doubling time and barrier formation of LEPI cells is faster than regular ARPE19 cells.
(a) Comparison between LEPI and ARPE19 cells shows that cell division rate of LEPI cells is 2.3 times
faster than that of regular ARPE19 cells (n = 12, *** p < 0.0001, determined with unpaired t-test with
Welch’s correction). The results are presented as the mean doubling-time ± standard deviation (SD)
from four independent cultures, each performed in triplicate. (b) LEPI cells (n = 7) form a barrier
against paracellular permeation similar to ARPE19 cells (n = 5). The apparent permeability coefficient
(Papp) of mannitol was similar in LEPI cells after culture of 7 days and in ARPE19 cells that were
cultured for 30 days. The bars display average values and error bar standard deviation (SD). (c) The
permeation of beta-blockers across the tight LEPI monolayers (cultured for 30 days) is related to
compound lipophilicity. The apparent permeability coefficients (Papp) are displayed as a range, and the
lines represent the average values (n = 3).
Since LEPI cells seemed to gain differentiated phenotype quickly in culture, we compared their
barrier properties after one week in culture to ARPE19 cells that had been cultured on filters for 30 days
(Figure 5b). LEPI cells form a barrier against paracellular diffusion in one week, as the apparent
permeation coefficients (Papp) of mannitol were similar in these two cases (Figure 5b). However, we
recorded even lower mannitol permeation values after 4-week LEPI-cultures (<0.9 × 10−6 cm/s, data
not shown) and thus, decided to perform the further barrier evaluation with cells cultured for 4 weeks.
The beta-blockers showed different permeation rates across the LEPI cell layer (Figure 5c). The
drug permeation in the LEPI cultures showed the similar rank-order as their lipophilicities (logD7.4
values, Figure 5c, and Table 2) and the Papp values in isolated bovine RPE-choroid (Table 2). The
Papp values of beta-blockers are 1.9- to 10.8-fold lower in LEPI cells than in the isolated RPE-choroid
(Table 2).
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Table 2. Permeability of drugs across LEPI cells and bovine RPE-choroid.
Compound logD7.4 (Predicted,ACDLabs) 1
Papp across LEPI Cells ±
SD (×10−6cm/s,
Apical-to-Basolateral)
Papp across Bovine
RPE-Choroid 2 ± SD
(×10−6 cm/s,
Apical-to-Basolateral)
Fold
Differences in Papp
(RPE-Choroid/LEPI)
atenolol −1.85 0.39 ± 0.15 * 2.00 ± 0.47 5.1
nadolol −0.86 0.37 ± 0.17 * 2.03 ± 0.46 5.5
timolol −0.35 0.78 ± 0.34 8.41 ± 2.7 10.8
pindolol −0.32 1.8 ± 0.57 3.48 ± 1.7 1.9
metoprolol −0.25 2.3 ± 0.68 10.6 ± 3.2 4.6
betaxolol 0.76 1.7 ± 0.68 10.3 ± 3.7 6.1
1 Values collected from the ChemSpider database (Royal Society of Chemistry); 2 Values reported by [7]. * Significantly
different from metoprolol (p < 0.05, determined with one-way ANOVA and the Holm–Sidak method. The LEPI
Papp data passed the normality and equal variance criteria determined with Shapiro–Wilk and Brown–Forsythe
methods, respectively).
4. Discussion
In this study, we present an RPE cell line, LEPI, that differentiates within 1 to 4 weeks after
sub-culture into a phenotype similar to primary RPE. Unlike the ARPE-19 cells, the LEPI cells rapidly
form cobblestone morphology, clear microvilli, and tight barrier in simple culture conditions. As
expected the LEPI and ARPE19 cells show an exact authentication match with the original ARPE19
cell line (Supplementary Materials), and as expected, the hfRPE cells did not have any matches in the
ATCC’s STR database. Cobblestone morphology can be achieved in ARPE19 cultures, but this requires
months in culture and specialized culture conditions [5,10].
4.1. Morphology and RPE-Specific Protein Expression of LEPI Cells Reveal the Differentiated Phenotype
LEPI cells display a cobblestone phenotype quickly after sub-culture (Figure 1e), and they even
form domes (Figure 4) that have been associated with differentiated phenotype with proper polarity
and tight junctions in hfRPE cultures [8,17]. We compared the microvillus formation by SEM and
showed that LEPI cells form distinct microvilli (Figure 2e), whereas it was lacking from regular ARPE19
cells according to SEM images (Figure 2a). Ezrin protein expression on the apical cell surface further
confirmed that the LEPI cells form appropriate microvilli (Figure 3a). Tight junctions were detected
in all studied cell models (Figure 2b,d,e and Figure 3a–c; occludin expression in lateral surfaces of
LEPI cells), and the TEM image revealed that ARPE19 cells do not grow as a true monolayer since
the cellular lateral surfaces are diagonal (Figure 2b). The pigmentation is lacking from the LEPI
cells (Figure 2f), but the existing RPE cell lines (ARPE19, D407) do not contain pigment either. The
hfRPE cells displayed only modest pigmentation (Figure 2d) compared to highly pigmented native
RPE [18]. Overall, the morphology of the LEPI cells is similar to ARPE19 cells that differentiated
to RPE-like phenotype in earlier studies after 2.5 to 4 months [5,13]. We confirmed the mature RPE
phenotype of LEPI cells with RPE-specific marker protein expression (BEST1 on the basal surface,
RPE65 in the cytoplasm; Figure 3b,c). Importantly, the cells phagocytosed the photoreceptor outer
segments (Figure 3d) verifying differentiated RPE-specific phenotype. Phagocytosis of the daily shed
photoreceptor outer segments is one of the key RPE functions maintaining the optimal conditions in
the sub-retinal space [1].
Epithelial-mesenchymal transition (EMT) has been suggested to cause the dedifferentiated ARPE19
phenotype [10]. The same phenomenon may take place also in hfRPE cultures if the cell–cell contacts are
lacking due to too low sub-culture density [17,19]. Interestingly, LEPI cells seem to be resistant towards
EMT, as their appearance is epithelial-associated (“cobblestone-like”) already 3 days after sub-culturing
even at low seeding densities (<10% of the culture plate, Figure 1e). The clear morphological difference
among regular ARPE19 and LEPI cells is evident immediately after sub-culture: ARPE19 cells are
fibroblast-like, whereas LEPI cells have cuboidal, epithelial shape 24 h after sub-culture (Figure 1c,d). In
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addition, the growth of LEPI cells is 2.3 times faster than that of ARPE19 cells (Figure 5a). Due to its fast
differentiation and ability to divide faster than the regular ARPE19 cells, LEPI cells are more convenient
to maintain and easily expanded for assays requiring large cell quantities than regular ARPE19. Rapid
differentiation without specialized culture medium makes the cell model cost-effective. These aspects
make LEPI cells suitable for high throughput assays in retinal biology and drug discovery.
4.2. LEPI Cells Are Suitable as an Outer Blood–Retinal Barrier Model
When we compared LEPI cell population to regular ARPE19 cells, we discovered that the LEPI
cells form a tight barrier in 7 days, while it takes 30 days for the ARPE19 cells to generate a comparable
barrier (Figure 5b). Paracellular permeation in the apical-to-basolateral direction in LEPI cells was
similar to paracellular permeability in bovine RPE-choroid explants in the basolateral-to-apical direction
(mannitol Papp approximately (1–2) × 10−6 cm/s) [20]. Thus, the permeation set-up with LEPI cells is
equivalent to the RPE-choroid tissue in a Ussing chamber as an outer blood–retinal barrier model.
Previously Mannermaa et al. [6] investigated ARPE19 cells as an outer blood–retinal barrier model.
They reported drug permeation values that were dependent on the molecular size and lipophilicity of
the permeants, but the Papp values of betaxolol, 6-carboxyfluorescein, and 40 kDa FITC-dextran were
3.2, 7.6, and 17.1 times higher than in the bovine RPE-choroid tissues, respectively [7]. As ARPE19 cells
kept in culture for 4 weeks still display a leaky barrier, and mannitol permeation after only one-week
culture was similar to 4-week ARPE19 culture (Figure 5b), we decided to further characterize the
permeation properties of the LEPI cells cultured for 4 weeks.
We aimed to define the capability of LEPI cells to re-produce the relationship between the
compound lipophilicity and permeability that was observed earlier in the bovine RPE-choroid [7]. For
that purpose, we used the same compounds (atenolol, nadolol, timolol, pindolol, metoprolol, and
betaxolol) as described in an earlier report [7]. These beta-blocking agents have a similar molecular
weight of 250 to 320 Da and pKa values around 9, but their logD7.4 values have a wide range from
−1.85 to +0.76 (Table 2). As in bovine RPE-choroid [7], the lipophilic beta-blockers (metoprolol and
betaxolol) permeated faster in the LEPI cultures than the hydrophilic compounds (atenolol, nadolol).
The difference between the high (e.g., metoprolol) and low permeability compounds (e.g., nadolol) was
6.2-fold in LEPI cells. The lipophilic drugs can permeate across the cellular lipid bilayer more easily
than hydrophilic ones as they can pass through the cell membranes, in addition to the paracellular route.
We also compared the permeation of the beta-blockers across the LEPI monolayer with the
published permeability values in the bovine RPE-choroid [7]. The LEPI cells did not only reproduce
the rank order of Papp values observed in bovine RPE-choroid experiments [7] (Figure 5c) but also
displayed tighter barrier as the Papp values were 2 to 19 times lower in LEPI cells than in the bovine
RPE-choroid (Table 2). Similar to our observations, Caco-2 cells cultured and studied on transwells
also display lower Papp values compared to human intestinal tissue studied with a Ussing chamber
system [21]. Even with this difference in observed experimental values, and the lack of linear correlation
in Papp values with Caco-2 and human intestine, the Caco-2 cell line is a valuable tool that is widely
used to predict the oral drug absorption in humans. Overall, LEPI cells constitute a promising model
for the outer blood–retinal barrier, because they form a tighter barrier than differentiated ARPE19
cells [6] and isolated bovine RPE-choroid [7,20]. Furthermore, the LEPI cells correctly demonstrate the
impact of permeant lipophilicity on membrane permeability. Further work is needed to establish the
cause of rapid growth and differentiation rate of LEPI cells. Comparison of epigenetic regulation of
ARPE19 and LEPI cells might reveal the difference, and lead to improved understanding of the RPE
development and biology.
5. Conclusions
In conclusion, we present new RPE cell model with improved barrier properties and mature RPE
phenotype. Our cell model is easy to handle without the need for specialized culture conditions and
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long differentiation times. In addition, LEPI cells divide and expand rapidly, making this new cell
model superior to regular ARPE19 in drug discovery and development.
Supplementary Materials: The following are available online at http://www.mdpi.com/1999-4923/11/8/412/s1.
Supplementary Materials: The cell line authentication by ATCC (PDF-file).
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